Aperam S.A.
APEMY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $2 | $2 | $1 | $1 |
| Enterprise Value | $3 | $3 | $3 | $2 |
| Revenue | $2 | $2 | $2 | $1 |
| % Growth | -0.4% | -0.2% | 12.7% | – |
| Gross Profit | $1 | $2 | $2 | $1 |
| % Margin | 85.6% | 100% | 100% | 100% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 5.2% | 6.8% | 3% | 8% |
| Net Income | -$0 | $0 | -$0 | $0 |
| % Margin | -1.5% | 1.1% | -1.1% | 0.8% |
| EPS Diluted | -0.34 | 0.25 | -0.25 | 0.16 |
| % Growth | -236% | 200% | -256.3% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |